potent stat6 inhibitor (MedChemExpress)
Structured Review

Potent Stat6 Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 74 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stat6/AS1517499/pmc13065056-42-7-2
Average 96 stars, based on 74 article reviews
Images
1) Product Images from "JMJD3 regulates the M2-like macrophage polarization and promotes the growth of breast cancer cells via STAT6/IRF4 axis"
Article Title: JMJD3 regulates the M2-like macrophage polarization and promotes the growth of breast cancer cells via STAT6/IRF4 axis
Journal: PLOS One
doi: 10.1371/journal.pone.0341313
Figure Legend Snippet: THP-1 cells were treated under different conditions: PMA (50 ng/ml) alone, or PMA (50 ng/ml) for 24 hours, followed by a medium change and subsequent treatment with IL-4 (20 ng/ml) and IL-13 (20 ng/ml) for 48 hours. After this, the medium was replaced with RPMI 1640 medium without FBS for 24 hours. Protein and mRNA were then extracted, and the supernatant was collected. (A) Morphological features of THP-1 cells under different conditions. Left: untreated THP-1 cells. Middle: PMA (50 ng/ml) for 24 hours. Right: PMA for 24 hours, followed by IL-4 and IL-13 (20 ng/ml) and IL-13 (20 ng/ml) for 48 hours. Scale bar: 50 μm. (B) Relative expression of Arg1 mRNA. (C) Relative expression of Arg1 protein. (D) Concentrations of TNF and IL-10 in the supernatant. (E) Relative mRNA expression of JMJD3 and IRF4. (F) Protein expression of JMJD3, p-STAT6-Y641, and IRF4. The experiments were replicated three times. * p < 0.05, ** p < 0.01, ***p < 0.001, ****p < 0.0001. Abbreviations: Arg1, arginase 1; PMA, Phorbol 12-myristate 13-acetate; IL-10, interleukin-10; TNF, tumor necrosis factor; JMJD3, Jumonji domain-containing protein 3; IRF4, interferon regulatory factor 4; p-STAT6, phosphorylated signal transducer and activator of transcription 6.
Techniques Used: Expressing
Figure Legend Snippet: THP-1 cells were first treated with PMA for 24 hours. Following this, AS1517499 (1μM) was administered for 30 minutes, and then the cells were treated with IL-4 and IL-13. 48 hours later, the medium was replaced with RPMI 1640 medium without FBS and cells were incubated for an additional 24 hours. Protein and mRNA were then extracted, and the supernatant was collected. (A) The mRNA expression of Arg1. (B) Concentrations of TNF in the supernatant of different groups of macrophages. (C) Concentrations of IL-10 in the supernatant of different groups of macrophages. (D) Expression of IRF4 mRNA. (E) Expression of JMJD3 mRNA. (F) Western blot analysis of JMJD3, p-STAT6, and IRF4 protein expression. The experiments were replicated three times. * p < 0.05, ** p < 0.01, ***p < 0.001, ****p < 0.0001. Abbreviations: JMJD3, Jumonji domain-containing protein 3; Arg1, arginase 1; TNF, tumor necrosis factor; IRF4, interferon regulatory factor 4; IL-10, interleukin-10; p-STAT6, phosphorylated signal transducer and activator of transcription 6.
Techniques Used: Incubation, Expressing, Western Blot
Figure Legend Snippet: Schematic illustration of the regulatory mechanism by which JMJD3 influences M2-like macrophage polarization and promotes breast cancer cell growth through the STAT6/IRF4 axis.
Techniques Used:
Related Articles
Silver Staining:Article Title: Targeting the macrophage mechanosensing regulator CKAP4 accelerates the inflammatory-to-proliferative transition in wound healing. Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER DNase I Roche Cat# 10104159001 Intracellular fixation & permeabilization buffer set Invitrogen Cat# 88-8824-00 Triton X-100 MP Biomedicals Cat# 194854 SlowFade diamond antifade mountant Invitrogen Cat# S36972 DAPI Thermo Scientific Cat# D1306 HEPES (1M) Gibco Cat# 15630080 RPMI 1640 Gibco Cat# 11875119 Methyldichlorosilane Sigma Aldrich Cat# 291501 (3-Aminopropyl)trimethoxysilane Sigma Aldrich Cat# 475149 TEMED Sigma Aldrich Cat# 8920-OP Acrylamide Sigma Aldrich Cat# A9099 N,N′-methylenebisacrylamide Sigma Aldrich Cat# 146072 Ammonium persulfate Sigma Aldrich Cat# A7460 Sulfo-SANPAH Thermo Scientific Cat# A35395 Fibronectin Sigma Aldrich Cat# 10838039001 iFluor 647 phalloidin Yeasen Cat# 40762ES75 LipofectamineTM LTX Invitrogen Cat# 15338100 LipofiterTM 3.0 HanBio Technology Cat# HB-LF3-1000 PF-573228 MCE Cat# HY-10461 ATN-161 MCE Cat# HY-13535 Cytochalasin D MCE Cat# HY-N6682 Blebbistatin MCE Cat# HY-13813 Nocodazole MCE Cat# HY-13520 AS1517499 MCE Cat# cDNA Synthesis:Article Title: Targeting the macrophage mechanosensing regulator CKAP4 accelerates the inflammatory-to-proliferative transition in wound healing. Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER DNase I Roche Cat# 10104159001 Intracellular fixation & permeabilization buffer set Invitrogen Cat# 88-8824-00 Triton X-100 MP Biomedicals Cat# 194854 SlowFade diamond antifade mountant Invitrogen Cat# S36972 DAPI Thermo Scientific Cat# D1306 HEPES (1M) Gibco Cat# 15630080 RPMI 1640 Gibco Cat# 11875119 Methyldichlorosilane Sigma Aldrich Cat# 291501 (3-Aminopropyl)trimethoxysilane Sigma Aldrich Cat# 475149 TEMED Sigma Aldrich Cat# 8920-OP Acrylamide Sigma Aldrich Cat# A9099 N,N′-methylenebisacrylamide Sigma Aldrich Cat# 146072 Ammonium persulfate Sigma Aldrich Cat# A7460 Sulfo-SANPAH Thermo Scientific Cat# A35395 Fibronectin Sigma Aldrich Cat# 10838039001 iFluor 647 phalloidin Yeasen Cat# 40762ES75 LipofectamineTM LTX Invitrogen Cat# 15338100 LipofiterTM 3.0 HanBio Technology Cat# HB-LF3-1000 PF-573228 MCE Cat# HY-10461 ATN-161 MCE Cat# HY-13535 Cytochalasin D MCE Cat# HY-N6682 Blebbistatin MCE Cat# HY-13813 Nocodazole MCE Cat# HY-13520 AS1517499 MCE Cat# In Vivo:Article Title: MS4A4A promotes macrophages M2 polarization via NF-κB /JAK-STAT6 axis, resulting GBM malignant progression. Article Snippet: The immunosuppressive tumor microenvironment (TME) is a major issue in the malignant progression of glioma patients.. The membrane spanning four domains A4A (MS4A4A) has a relationship with M2 polarization of macrophages, and participates in the malignant progression of various cancers.. Therefore, exploration of the key role of MS4A4A contributing to glioma biological processes is urgently needed. Injection:Article Title: MS4A4A promotes macrophages M2 polarization via NF-κB /JAK-STAT6 axis, resulting GBM malignant progression. Article Snippet: The immunosuppressive tumor microenvironment (TME) is a major issue in the malignant progression of glioma patients.. The membrane spanning four domains A4A (MS4A4A) has a relationship with M2 polarization of macrophages, and participates in the malignant progression of various cancers.. Therefore, exploration of the key role of MS4A4A contributing to glioma biological processes is urgently needed. Cell Culture:Article Title: Role of uridine triggering M2 macrophage polarization to alleviate LPS-induced acute lung injury through the STAT6 signaling pathway. Article Snippet: Acute respiratory distress syndrome (ARDS), the most severe presentation of acute lung injury (ALI), involves diffuse pulmonary inflammation and edema, with hypoxemic respiratory failure as the end result.. Given the high mortality and limited therapeutic options, the development of novel interventions is urgently needed.. Effective control of excessive pulmonary inflammation and modulation of alveolar macrophage polarization play critical roles in disease progression. Control:Article Title: Role of uridine triggering M2 macrophage polarization to alleviate LPS-induced acute lung injury through the STAT6 signaling pathway. Article Snippet: Acute respiratory distress syndrome (ARDS), the most severe presentation of acute lung injury (ALI), involves diffuse pulmonary inflammation and edema, with hypoxemic respiratory failure as the end result.. Given the high mortality and limited therapeutic options, the development of novel interventions is urgently needed.. Effective control of excessive pulmonary inflammation and modulation of alveolar macrophage polarization play critical roles in disease progression. |
